Kinetics of sulfamethylthiadiazole acetylation and excretion in humans
โ Scribed by Eino Nelson; Inge O'Reilly
- Publisher
- John Wiley and Sons
- Year
- 1961
- Tongue
- English
- Weight
- 333 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
โฆ Synopsis
In studying the postabsorptive and postequilibrative phases of sulfamethylthiadiazole excretion and acetylation in humans, it was found that urinary excretion of unchanged drug and its acetylation could be described by competitive first-order p c e s s e s . The excretion of acetylated drug was also by a first-order process that ollowed its first-order acetylation. The mean half-life for excretion of unchanged drug was about one and one-half hours, for formation of acetylated drug about fifteen hours, and for excretion of acetylated drug about one-half hour. Experimental values of excretion were in excellent agreement with values predicted by equations previously developed to describe the kinetic model found to hold in the present work.
T WAS RECENTLY reported that the acetylation
๐ SIMILAR VOLUMES
## Abstract A single oral dose of the diuretic chlorthalidone (100 or 200 mg) was given to six cholecystectomized patients with Tโtube drainage of the common bile duct, and the 24 h bile and urine were collected during 3โ7 days. Urinary recovery of chlorthalidone was 23โ27 per cent of the dose, whi
In humans sulfa-2-monomethoxine (S) is metabolized by N,-acetylation (39.9 f 8.0 per cent). After an oral dose, S is eliminated biphasically (t%, 5.2 f 1.6 h and 13.2 f 3.4h) which is similar in both fast and slow acetylators. The metabolite N,-acetylsulfa-2monomethoxine (N, ) is eliminated monophas